Robert Truitt

A subsidiary of Western & Southern Financial Group, Inc., Columbus Mutual Life Insurance Co. is headquartered in Cincinnati, Ohio. The firm provides life insurance services to their clients. Their products, including mutual funds and equities, are available to registered representatives through their subsidiary, Capital Analysts. Columbus Mutual Life Insurance Co. was founded in 1906

Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN.

HemoCleanse, Inc. develops sorbent-based technologies to remove toxins from blood. It offers HemoCleanse-DT, a sorbent-based centrifuge-like device for liver dialysis and drug overdose detoxification applications; and HemoCleanse-PF, a sorbent-based centrifuge-like device for removing protein-bound toxins from plasma in applications, such as treatment of sepsis and autoimmuned diseases. The firm also provides AmSorb Ammonium sorbent for use in HemoCleanse; as an oral sorbent for urea control in the treatment of patients with renal insufficiency or end stage renal disease; and for ammonium removal in treatment of patients with chronic liver diseases. The company was founded by Stephen R. Ash and Robert B. Truitt in 1989 and is headquartered in Lafayette, IN.

Renal Solutions, Inc. develops, manufactures and distributes medical devices for dialysis. It commercializes the Allient Sorbent Hemodialysis Systems, a technology/service solution for the chronic and acute dialysis market. The company was founded by Peter M. DeComo on August 1, 2000 and is headquartered in Warrendale, PA.

Allen-Bradley Co., Inc. manufactures aerospace development and industrial control equipment. The company manufactures automation products like programmable logic controllers. The company was founded by Lynde Bradley and Dr. Stanton Allen in 1903 and is headquartered in Milwaukee, WI

General Motors Corp. (NYSE: GM), one of the world's largest automakers, was founded in 1908, and today manufactures cars and trucks in 34 countries. With its global headquarters in Detroit, GM employs 244,500 people in every major region of the world, and sells and services vehicles in some 140 countries. The company brands are Buick, Cadillac, Chevrolet, GMC, GM Daewoo, Holden, HUMMER, Opel, Pontiac, Saab, Saturn, Vauxhall and Wuling. GM's largest national market is the United States, followed by China, Brazil, the United Kingdom, Canada, Russia and Germany. GM's OnStar subsidiary is the industry leader in vehicle safety, security and information services. GM is the majority shareholder in GM Daewoo Auto & Technology Co. of South Korea, and has product, power train and purchasing collaborations with Suzuki Motor Corp. and Isuzu Motors Ltd. of Japan. GM also has advanced technology collaborations with Chrysler LLC, Daimler AG, BMW AG and Toyota Motor Corp. and vehicle manufacturing ventures with several automakers around the world, including Toyota, Suzuki, Shanghai Automotive Industry Corp. of China, AVTOVAZ of Russia and Renault SA of France. Genuine GM Parts and accessories are sold under the GM, GM Performance Parts, GM Good wrench and ACDelco brands through GM Service and Parts Operations, which supplies GM dealerships and distributors worldwide. GM engines and transmissions are marketed through GM Power train.

Zurex Pharma, Inc. provides safe and effective anti-microbial products. Its products include ZuraPrep, a pre-surgical skin preparation for the prevention of SSI; ZurAsept, an antimicrobial and antithrombotic catheter solution to reduce CRBSI; and ZuraGard that prevents extra-luminal or exit site wound CRBSI. The company was founded in April 2008 and is headquartered in Middleton, WI.

ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA.